Madison Wealth Partners Inc acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, Holdings Channel reports. The firm acquired 8,024 shares of the company’s stock, valued at approximately $1,031,000.
Several other large investors also recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC purchased a new position in Merck KGaA during the second quarter worth about $25,000. Rakuten Securities Inc. purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at about $27,000. Bard Associates Inc. bought a new stake in shares of Merck KGaA during the 2nd quarter valued at about $60,000. Kilter Group LLC bought a new stake in shares of Merck KGaA during the 2nd quarter valued at about $62,000. Finally, Addison Advisors LLC bought a new position in shares of Merck KGaA in the second quarter worth approximately $90,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Up 0.7%
Shares of MKGAF opened at $163.21 on Friday. The firm’s 50 day simple moving average is $162.62 and its 200 day simple moving average is $148.46. The company has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
